kras mutation and glutathion glynac

kras mutation and glutathion glynac Oncogenic Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Isoform-Specific Destabilization of the Active

Name: kras mutation and glutathion glynac Oncogenic Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Isoform-Specific Destabilization of the Active
Brand: www.ohotnichi-sezoni.com
SKU: 19980302485
Price: 26.37 USD
Availability: InStock
Rating: 4.4716000000000005 (17 reviews)

Isoform Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D: Cell Reports Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges PMC KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences KRAS OriGene Technologies Inc. Pancreatic Cancer: Advances and Challenges PMC

SKU: 19980302485 · From www.ohotnichi-sezoni.com

4.5

USD26.37 USD47.37

Pay in 4 interest-free payments of $6.59 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

OCA treatment ameliorated high-fat diet (HFD)-induced dysplasia, potentially by reducing deleterious secondary BAs (e.g., DCA, TDCA), decreasing microbial bile salt hydrolase (BSH) expression, and favorably reshaping the tumors immune landscape (128), thereby potentially reversing an immunosuppressive TIME